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Background: Prolonged pre-hospital time for acute myocardial infarction (AMI) is associated
with decreased indication for primary percutaneous coronary intervention (PCI). However, the
efﬁcacy of primary PCI in AMI patients with prolonged pre-hospital time has not been fully
investigated in Japan.
Methods and results: A total of 3010 consecutive AMI patients admitted to AMI-Kyoto Multi-
Center Risk Study Group hospitals were retrospectively analyzed, and the clinical characteristics
and in-hospital prognosis of these patients were reviewed. Patients with pre-hospital delay
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[elapsed time (ET) > 12 h] had a lower frequency of Killip≥ 3 (9.3%) and less frequently received
primary PCI (77.7%) compared with patients with ET≤ 12 h. In the ET > 12 h group, older patients
or patients with MI history tended to be complicated by heart failure. Primary PCI was performed
for patients with ET > 12 h, irrespective of the severity of heart failure [Killip 1 (78.7%) vs Killip≥ 2
(74.0%); p = 0.3827]. On multivariate logistic regression analysis, age [odds ratio (OR) 1.053], MI
history (OR 2.860), Killip≥ 2 (OR 10.235), and multi-vessels or left main coronary artery as culprit
(OR 11.712) were signiﬁcant independent positive predictors of in-hospital mortality for patients
with ET > 12 h. Practice of primary PCI was not a signiﬁcant negative predictor for patients with
ET > 12 h (OR 0.812), but it was for patients with ET≤ 12 h (OR 0.425).
Conclusions: These ﬁndings indicate that patients with ET > 12 h have a less severe condition and
less frequently receive primary PCI compared with patients with ET≤ 12 h. Although primary PCI
is often performed for these patients irrespective of the severity of heart failure, no preferable
effect of primary PCI on the in-hospital mortality is demonstrated. In contrary, practice of primary
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Introduction
Although acute myocardial infarction (AMI) is associated
with relatively high morbidity and mortality, it is well known
that timely reperfusion therapy can result in dramatically
improved patient clinical outcomes [1—3]. However, some
of those patients who arrive at hospital late after symptom
onset often lose their opportunity to receive reperfusion
therapy. From the early days of interventional cardiology,
there have been discussions about the relative beneﬁts of
reperfusion therapy beyond 12 h after symptom onset [4].
Some recent studies failed to show clinical beneﬁts [5]
such as improvement of indices of left ventricular function
[6] following mechanical reperfusion late after ST-elevation
myocardial infarction (STEMI) in stable patients. However,
many other reports have supported the signiﬁcance of late
reperfusion of infarct-related artery [7]. This discrepancy
might be derived from the inappropriate management and
risk stratiﬁcation of clinical background for patients with
delayed (>12 h) pre-hospital time during the course of AMI.
Several studies regarding AMI have been reported so far
in Japan. The JACSS (Japanese acute coronary syndrome
study) database included more than 5000 consecutive AMI
patients and the results vividly displayed the modern state
of AMI in Japan [8]. The AMI-Kyoto Multi-Center Risk Study, a
large multi-center observational study in which 16 collabo-
rating hospitals in Kyoto prefecture collected demographic,
procedural, and outcome data on AMI patients, was estab-
lished in 2000 in order to analyze such data and establish
an emergency-hospital network for heart diseases in Kyoto
[9—11]. The present study used the AMI-Kyoto Multi-Center
Risk Study database to retrospectively investigate the cir-
cumstances of AMI patients who arrived at hospital more
than 12 h after symptom onset in order to elucidate appro-
priate management and risk stratiﬁcation of these patients.
Methods
Patient populationBetween January 2000 and December 2007, 3010 consec-
utive patients with a diagnosis of AMI were admitted to
AMI-Kyoto Multi-Center Risk Study Group hospitals. Of these,
cases of in-hospital AMI onset (n = 88) and those receiving
ﬁbrinolysis (n = 55) were excluded. Detailed data on clini-
a
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dctor of in-hospital mortality for patients with ET≤ 12 h.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
al background were available in 2391 remaining patients.
ackgrounds of the patients whose data were excluded from
his analysis were similar to those of our interest. These
391 patients were divided into three groups according to
he total length of pre-hospital time; patients whose pre-
ospital elapsed time (ET) from the symptom onset was
ithin 3 h (n = 1370), 3 < ET≤ 12 h (n = 644), and over 12 h
n = 377). The 3- and 12-h pre-hospital ET are indices indi-
ated in the American College of Cardiology (ACC)/American
eart Association (AHA) guidelines for the management of
atients with STEMI. Pre-hospital ET in our study is deﬁned
s the time from AMI onset to presentation at hospitals with
rimary percutaneous coronary intervention (PCI) facilities.
ccordingly, patients transferred to interventional centers
rom local hospitals without primary PCI facilities were
ncluded.
We retrospectively compared clinical backgrounds, coro-
ary risk factors, and in-hospital outcomes among the
roups. Next, we noted those who were in the ET > 12 h
roup, and compared their clinical characteristics and
ngiographic ﬁndings after stratifying by Killip classiﬁca-
ion. Moreover, patients in the delayed presentation group
fter classiﬁcation for the severity of congestive heart fail-
re (CHF) were examined to see whether practice of PCI
ffected patient’s characteristics and in-hospital mortality.
ultivariate logistic regression analysis demonstrated pre-
ictors of in-hospital mortality of the patients who received
mergency coronary angiography (CAG) among the study
opulation.
The diagnosis of AMI required at least two of the fol-
owing three criteria: (1) characteristic clinical symptoms
nd history; (2) serial changes on electrocardiogram (ECG)
uggesting infarction (Q-waves) or injury (ST-segment eleva-
ion); and (3) transient increase in cardiac enzymes to more
han twofold the normal laboratory limit.
ata collectionnd risk factors [i.e., smoking, hypertension, diabetes mel-
itus (DM), and dyslipidemia] were recorded. Hypertension
as deﬁned as systemic blood pressure≥ 140/90mmHg
r the presence of anti-hypertensive treatment; DM was
eﬁned as fasting blood sugar≥ 126mg/dl or the pres-
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Table 1 Clinical characteristics of the study patients classiﬁed by pre-hospital elapsed time (ET) from the symptom onset to
admission to hospitals with primary PCI facilities.
ET≤ 3 h 3 < ET≤ 12 h ET > 12 h
(n = 1370) p (n = 644) p (n = 377)
Age (year) 66.5± 12.5 0.0084 69.1± 12.6 0.4205 68.4± 12.5
Male (%) 1047 (76.5) 0.1871 433 (67.2) 0.0455 276 (73.2)
MI history (%) 177 (12.9) 0.1015 60 (9.3) 0.7996 37 (9.8)
Risk factors
Smoking (%) 530 (38.7) 0.0603 211 (32.8) 0.8292 126 (33.4)
Hypertension (%) 620 (45.3) 0.606 321 (49.9) 0.3593 177 (46.9)
Diabetes mellitus (%) 334 (24.4) 0.0398 161 (25.0) 0.1103 112 (29.7)
Dyslipidemia (%) 476 (34.7) 0.6002 207 (32.1) 0.6985 126 (33.4)
Killip 3/4 (%) 197 (14.4) 0.0098 84 (13.0) 0.0708 35 (9.3)
Onset to door (hr) 1.3± 0.8 <0.0001 5.8± 2.4 <0.0001 28.5± 23.0
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oAmbulance use (%) 779 (56.9) <0.00
Referral (%) 225 (16.4) <0.00
p-Value compared with ET > 12 h group. MI, myocardial infarction;
nce of speciﬁc treatment; dyslipidemia was deﬁned as
otal cholesterol≥ 220mg/dl or the presence of cholesterol-
owering agents. After informed consent to participate
n the AMI-Kyoto Multi-Center Risk Study was conﬁrmed
y each patient, all in-hospital data were transmitted to
he center located at the Department of Cardiovascular
edicine in Kyoto Prefectural University School of Medicine
or analysis. The study protocol was approved by the ethics
ommittee of each hospital.
mergency CAG and reperfusion therapy
mergency CAG was performed using the standard tech-
ique. Coronary ﬂow in the infarct-related artery was
raded according to the classiﬁcation used in the thrombol-
sis in myocardial infarction (TIMI) trial. Signiﬁcant stenosis
n the coronary artery was deﬁned as at least 75% reduc-
ion in the internal diameter of the right, left anterior
escending, or left circumﬂex coronary artery and the major
ranches, or a 50% reduction in the internal diameter of the
eft main coronary artery (LMCA). Non-signiﬁcant stenosis
as deﬁned as coronary arterial narrowing less than sig-
iﬁcant stenosis. Diseased vessels were characterized as
oronary arteries with signiﬁcant stenosis. Culprit lesions
n multi-vessels were deﬁned as simultaneous thromboses
f multiple coronary arteries on initial CAG. Primary PCI
as subsequently performed as the situation warranted. PCI
trategies were left to the discretion of the attending car-
iologist.
tatistical analysis
ategorical data are expressed as n (%) and continuous data
s mean± SD. Groups concerned were compared using the
hi-square test for discrete variables and unpaired Student’s
-test for continuous variables, according to standard sta-
istical methods. The odds ratio (OR) and 95% conﬁdence
ntervals (CI) assessing the risk of in-hospital mortality were
stimated by multivariate logistic regression analysis. In all
nalyses, signiﬁcance was accepted at p < 0.05.
a
w
s
i
s164 (25.5) <0.0001 49 (13.0)
264 (41.0) 0.0357 180 (47.7)
diabetes mellitus.
esults
atient characteristics and risk factors
he clinical characteristics and risk factors of three groups
re summarized in Table 1. In the ET≤ 3 h group, there were
igniﬁcantly more patients who were relatively young, had
o DM, and had severe heart failure (Killip≥ 3) on admis-
ion, compared to the distributions of those factors in the
T > 12 h group. There were more females in the 3 < ET≤ 12 h
roup compared to the gender distribution in the ET > 12 h
roup. Patients in the ET > 12 h group less frequently used an
mbulance and were more often transferred from primary
ospitals to intervention centers.
n-hospital outcomes
e compared in-hospital clinical outcomes of the study
atients as shown in Table 2. In the ET > 12 h group, PCI
as performed less frequently, however, there was no dif-
erence in the in-hospital mortality compared to that in
he other groups. Cardiac-related deaths were more fre-
uently observed in the ET≤ 3 h group compared to that in
he ET > 12 h group. Patients showed signiﬁcantly lower max
reatine phosphokinase (CPK) value, which is thought to be
erived from lack of the measurements of peak CPK value
ecause of the delayed presentation.
linical characteristics and angiographic data of
he delayed presentation
e divided the study patients in the ET > 12 h group based
n the Killip classiﬁcation (Killip 1, n = 300; Killip≥ 2, n = 77),
s demonstrated in Table 3. Patients in Killip≥ 2 group
ere signiﬁcantly older, more frequently had an MI history,
howed a greater max CPK value, and had a higher mortal-
ty ratio than those in the Killip 1 group. There were also
igniﬁcant differences in the distribution of culprit lesions
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Table 2 In-hospital outcomes of the study patients.
ET≤ 3 h 3 <ET≤ 12 h ET > 12 h
(n = 1370) p (n = 644) p (n = 377)
PCI (%) 1233 (90.0) <0.0001 558 (86.6) <0.0001 293 (77.7)
Length of hospital stay (days) 21.9± 22.7 0.9852 21.7± 16.6 0.8426 21.9± 18.5
Max CPK (IU/L) 2692± 2616 <0.0001 2585± 2397 <0.0001 1987± 2015
Death (%) 125 (9.1) 0.1028 79 (12.3) 0.8759 45 (11.9)
Cardiac-related (%) 105 (84.0) 0.0278 65 (82.3) 0.1144 33 (73.3)
Shock 49 19 7
Heart failure 35 26 12
Rupture 8 13 6
Vf 13 7 8
Noncardiac-related (%) 18 (14.4) 10 (12.7) 12 (26.7)
rcut
P
T
g
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m
c
LUnknown (%) 2 (1.6)
p-Value compared with ET > 12 h group. ET, elapsed time; PCI, pe
ventricular ﬁbrillation.
and number of diseased vessels between the two groups. No
signiﬁcant differences in the frequency of PCI in both groups
were demonstrated (78.7% vs 74.0%; p = 0.3827).
Effects of primary PCI
Table 4 shows the clinical characteristics of the patients in
the ET > 12 h group, individually classiﬁed by whether pri-
mary PCI was performed or not. Practice of primary PCI did
not affect in-hospital mortality in both the Killip 1 group
(4.7% vs 4.7%; p = 0.9929) and the Killip≥ 2 group (36.8% vs
50.0%; p = 0.3019).
m
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Table 3 Clinical characteristics and angiographical ﬁndings of th
stratiﬁed by Killip classiﬁcation.
Killip 1 (n = 300)
Age (year) 67.5± 12.5
Male (%) 223 (74.3)
MI history (%) 21 (7.0)
Onset to door (h) 29.4± 23.5
Length of hospital stay (days) 21.2± 16.0
Max CPK (IU/L) 1687.8± 1714.8
CAG (%) 267 (89.0)
Culprit lesions
RCA (%) 78 (29.2)
LAD (%) 125 (46.8)
LCX (%) 60 (22.5)
LMCA (%) 1 (0.4)
Multi-vessels (%) 3 (1.1)
No. of diseased vessels
1 (%) 158 (59.2)
2< (%) 108 (40.4)
LMCA (%) 2 (0.7)
PCI (%) 236 (78.7)
Death (%) 14 (4.7)
MI, myocardial infarction; CPK, creatine phosphokinase; CAG, corona
descending artery; LCX, left circumﬂex artery; LMCA, left main corona4 (5.0) 0 (0.0)
aneous coronary intervention; CPK, creatine phosphokinase; Vf,
redictors of in-hospital mortality
o evaluate the contribution of clinical background, angio-
raphic ﬁndings, and practice of primary PCI, multivariate
ogistic regression analysis using all available variables (age,
ale, previous MI, hypertension, DM, dyslipidemia, Killip
lass ≥2 at admission, number of diseased vessels ≥2 or
MCA, multi-vessels or LMCA as culprit, practice of pri-
ary PCI) of the patients who received emergency CAG was
erformed for overall death during hospitalization in the
T > 12 h group as well as in the ET≤ 12 h group (Table 5).
atient age and Killip class≥ 2 at admission were inde-
endent positive predictors of in-hospital mortality in both
e patients with pre-hospital delay [elapsed time (ET) > 12 h]
Killip≥ 2 (n = 77) p-Value
72.3± 11.8 0.0024
53 (68.8) 0.3308
16 (20.8) 0.0003
25.3± 20.5 0.1658
24.9± 25.9 0.1129
3162.5± 2608.3 <0.0001
70 (90.9) 0.6275
16 (22.9) 0.0275
38 (54.3)
11 (15.7)
3 (4.3)
2 (2.8)
31 (44.3) 0.0308
38 (54.3)
4 (5.7) 0.0046
57 (74.0) 0.3827
31 (40.3) <0.0001
ry angiography; RCA, right coronary artery; LAD, left anterior
ry artery; PCI, percutaneous coronary intervention.
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Table 4 Clinical characteristics of the patients with delayed (elapsed time > 12 h) pre-hospital time classiﬁed by the severity
of Killip classiﬁcation according to whether primary percutaneous coronary intervention (PCI) was performed.
Killip 1 (n = 300) Killip≥ 2 (n = 77)
PCI(+) (n = 236) PCI(−) (n = 64) p PCI(+) (n = 57) PCI(−) (n = 20) p
Age (year) 66.8± 11.9 69.9± 14.5 0.0775 71.4± 12.1 74.7± 10.6 0.2893
Male (%) 177 (75.0) 46 (71.9) 0.6117 39 (68.4) 14 (70.0) 0.8956
Time from onset (h) 28.1± 22.8 34.0± 25.7 0.0753 25.1± 21.3 25.6± 18.4 0.9398
Length of hospital stay (days) 21.6± 16.6 19.4± 13.4 0.322 23.7± 20.7 28.5± 37.3 0.4822
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wMax CPK (IU/L) 1846± 1835 1093± 9
Death (%) 11 (4.7) 3 (4.7)
CPK, creatine phosphokinase.
roups. Previous MI andmulti-vessels or LMCA as culprit were
ndependent positive predictors of in-hospital mortality in
he ET > 12 h group, but not in the ET≤ 12 h group. Number
f diseased vessels ≥2 was an independent positive predic-
or of in-hospital mortality in the ET≤ 12 h group, but not
n the ET > 12 h group. In contrast, male gender and prac-
ice of primary PCI were independent negative predictors of
n-hospital mortality in the ET≤ 12 h group, but not in the
T > 12 h group.
iscussion
he major ﬁndings of the present multi-center study are as
ollows: AMI patients with pre-hospital delay (ET > 12 h) were
ess frequently treated with primary PCI for infarct-related
rtery compared with those who presented at hospital
ithin 12 h from symptom onset. Primary PCI for patients
ith delayed pre-hospital time was performed irrespective
f the severity of heart failure on admission. When all the
atients were divided into hospitalization in the ET > 12 h
roup and that in the ET≤ 12 h group, previous MI and
ulti-vessels or LMCA as culprit were independent positive
redictors of in-hospital mortality in the ET > 12 h group,
ut not in the ET≤ 12 h group. Number of diseased ves-
els ≥2 or LMCA was an independent positive predictor of
n-hospital mortality in the ET≤ 12 h group, but not in the
a
(
h
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Table 5 Predictors of in-hospital mortality of the patients who re
(ET)≤ 12 h and ET > 12 h groups evaluated by multivariate logistic r
ET≤ 12 h
OR 95% CI
Age 1.047 1.028—1.067
Male 0.552 0.373—0.816
Previous MI 1.104 0.642—1.896
HT 0.997 0.680—1.462
DM 0.965 0.621—1.499
Dyslipidemia 0.873 0.577—1.323
Killip≥2 9.688 6.523—14.389
No. of diseased vessels≥2 or LMCA 1.695 1.153—2.491
Multi-vessels or LMCA as culprit 1.869 0.804—4.345
PCI 0.425 0.234—0.772
OR, odds ratio; CI, conﬁdence interval; MI, myocardial infarction; HT,
artery; PCI, percutaneous coronary intervention.0.0022 3557± 2754 2098± 1831 0.0316
0.9929 21 (36.8) 10 (50.0) 0.3019
T > 12 h group. In contrast, male gender and practice of
rimary PCI were independent negative predictors of in-
ospital mortality in the ET≤ 12 h group, but not in the
T > 12 h group.
This was the ﬁrst study to investigate the clinical man-
festations and determinants of in-hospital mortality in
apanese AMI patients with prolonged pre-hospital time.
ime from symptom onset to reperfusion is an impor-
ant predictor of patients’ clinical outcomes. The ACC/AHA
uidelines for the management of patients with STEMI
12,13] indicate that primary PCI should be performed in
atients with STEMI or MI with new or presumably new left
undle branch block (LBBB) who can undergo PCI of the
nfarct artery within 12 h of symptom onset, if performed
n a timely fashion by persons skilled in the procedure.
he indication for primary PCI for patients with onset of
ymptoms within the prior 12—24 h is classiﬁed as Class IIa
reasonable to perform procedure) under certain conditions.
erforming mechanical intervention for stable patients who
resented at hospital more than 24 h after symptom onset
as deﬁned as undesirable (Class III).
Total pre-hospital delay (symptom onset to hospital
dmission) is divided into two components: patient delay
symptom onset until call for medical help), and home-to-
ospital delay (call for help until hospital admission) [14].
o achieve a better prognosis of the AMI patient, energy
ceived emergency coronary angiography in both elapsed time
egression analysis.
ET > 12 h
p OR 95% CI p
<0.0001 1.053 1.012—1.096 0.0108
0.0029 1.63 0.616—4.313 0.3251
0.7209 2.86 1.006—8.131 0.0488
0.9876 1.452 0.620—3.401 0.3902
0.8735 0.736 0.308—1.758 0.4906
0.5231 0.698 0.278—1.752 0.4436
<0.0001 10.235 4.448—23.549 <0.0001
0.0072 0.658 0.272—1.592 0.3528
0.1461 11.712 1.952—70.258 0.0071
0.005 0.812 0.273—2.413 0.7078
hypertension; DM, diabetes mellitus; LMCA, left main coronary
coro
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should be directed to shortening the total pre-hospital delay.
Guidelines were drawn up in order to alert emergentmedical
service systems to shorten home-to-hospital delay. How-
ever, these efforts are weakened by patient delay, which
is said to account for almost two thirds of the time from
the onset of symptoms to treatment. Many reports have
shown that various factors such as age [15], gender [16],
pre-infarction angina [17], and cognitive and emotional fac-
tors including the patient’s beliefs about causes [18,19] were
associated with patient delay. Our data suggest that factors
such as advanced age, female sex, and DM are associated
with patient delays. It is possible that these patients com-
monly demonstrate atypical symptoms of AMI, which might
explain pre-hospital patient delay as well as diagnostic delay
in the hospital [20].
Patients in the ET≤ 3 h group more often used ambu-
lance services to arrive at hospital, while referral to the
PCI center from a primary hospital showed increased preva-
lence in the ET > 12 h group. In patients initially admitted to
hospitals without primary PCI facilities for diagnosis before
transferal to an interventional center, there was consid-
erable delay at the local hospitals before departure [21].
In such cases, pre-hospital establishment of the diagnosis
can reduce treatment delay and increase the proportion of
patients being eligible for primary PCI.
Current guidelines indicate that all patients with STEMI
presenting within 12 h after onset of typical symptoms
should receive reperfusion therapy. In terms of the quality of
reperfusion, PCI is considered superior to thrombolysis [22].
Fibrinolysis therapy was actually carried out for 55 (1.8%) of
the overall patients, and only three of these patients (0.8%)
were in the ET > 12 h group. However, this treatment should
be considered discretionary as the situation warrants.
Patients with signs of left ventricular failure (Killip≥ 2)
are also reported to have a signiﬁcantly shorter patient delay
[23]. This was also true in our data. Patients with no sign of
heart failure comprised the majority of the ET > 12 h group.
As regards primary PCI for patients in the ET > 12 h group,
our data suggest that it was performed with relatively high
frequency (77.7%), irrespective of the severity of heart fail-
ure [24]. Because the determination of the primary PCI was
left to the discretion of the attending cardiologists in our
study, we have no exact information about what is an indi-
vidual decisive factor of primary PCI for the patients in the
ET > 12 h group. Although the statistical difference was not
signiﬁcant, there was a tendency toward reduced length
of hospital stay and reduced in-hospital mortality for the
Killip≥ 2 patients in the ET > 12 h group who underwent pri-
mary PCI as shown in Table 4. The ACC/AHA guidelines also
recommend that the indication of primary PCI for patients
with a pre-hospital delay greater than 12 h is deﬁned in rela-
tion to the severity of heart failure. Therefore, we may be
able to demonstrate the good efﬁcacy of primary PCI for the
patients with ischemia-related heart failure in the ET > 12 h
group by analyzing many more cases in the future.
We showed that practice of primary PCI for the patients
in the ET≤ 12 h group is a signiﬁcant negative predictor
of in-hospital mortality. We would like to emphasize that
primary PCI for the patients in the ET≤ 12 h group, in
which more critical cases are included, can reduce their in-
hospital mortality ratio to the extent of that in the ET > 12 h
group.
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imitations
here are several study limitations. The major one is that
his study design is a retrospective observational analysis.
he diagnosis of AMI is described as above. ‘‘ST-elevation
I’’ was not discriminated from ‘‘non-ST-elevation MI’’ in
ur study. Because some cases lacked accurate information
bout the time of symptom onset, these cases were excluded
rom our investigation. We focused on pre-hospital delay
orresponding to the time from the symptom onset to pre-
entation at hospitals with primary PCI facilities. Although
oor-to-balloon time is also an important factor in reper-
usion therapy for AMI patients, it is not considered in this
tudy. We did not examine the expertise of individual PCI
perators, which has been reported to play a crucial deter-
inant in clinical outcome.
onclusion
he present study demonstrates the evidence that AMI
atients with delayed pre-hospital time (ET >12 h) were
ften treated with primary PCI for infarct-related artery,
rrespective of the severity of heart failure. Although age,
revious MI history, Killip≥ 2 at admission, and multi-vessels
r LMCA as culprit were signiﬁcant independent positive pre-
ictors of in-hospital mortality for this group, the practice
f primary PCI was not a negative factor. On the other hand,
rimary PCI for the patients in the ET≤ 12 h group is a signif-
cant negative predictor of in-hospital mortality. ACC/AHA
uidelines recommend primary PCI for those patients even
eyond 12 h after symptom onset under certain conditions
uch as persistent ischemia-related heart failure. However,
e could not show any preferable effects of primary PCI on
he in-hospital mortality even after stratifying patients in
he ET > 12 h group with Killip classiﬁcation.
ppendix A.
he following institutions and principal investigators partic-
pated in the present study as the AMI-Kyoto Multi-Center
isk Study Group.
Kyoto City Hospital: Matsubara K, Shima M, Kiyama M,
awanishi T, Nakajima N, Fukui K; Kyoto Kizugawa Hospi-
al: Miyanaga H, Nakagawa T, Matsui H, Kunieda Y; Kyoto
irst Red Cross Hospital; Okada T, Shima T, Hyogo M,
rihara M, Takeda M, Matsui A; Kyoto Second Red Cross
ospital: Fujita H, Inoue K, Matsuo A, Sakatani T, Tsubaki-
oto Y; Social Insurance Kyoto Hospital: Yamada C, Oda
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